Thaw-and-use target cells pre-labeled with calcein AM for antibody-dependent cell-mediated cytotoxicity assays

Journal of Immunological Methods

Volumn 447, Issue , 2017, Pages 37-46

  Chung, Shan ^a   Nguyen, Van ^a   Lin, Yuwen Linda ^a   Kamen, Lynn ^a   Song, An ^a  

^a GENENTECH INC   (United States)

Author keywords

Antibody dependent cell mediated cytotoxicity; Calcein AM; Cell based assay; Cryopreservation; Thaw and use cells

Indexed keywords

CALCEIN; CALCEIN AM; UNCLASSIFIED DRUG; FLUORESCEIN DERIVATIVE; MONOCLONAL ANTIBODY;

ACCURACY; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CALCEIN-AM ASSAY; CELL VIABILITY; CONTROLLED STUDY; CRYOPRESERVATION; CYTOTOXICITY ASSAY; FREEZE THAWING; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; TARGET CELL; THAW AND USE PRE LABELED TARGET CELL; CYTOTOXICITY TEST; IMMUNOLOGY; MONONUCLEAR CELL; PROCEDURES; SPECIMEN HANDLING; STAINING; STANDARDS;

ANTIBODIES, MONOCLONAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; CRYOPRESERVATION; CYTOTOXICITY TESTS, IMMUNOLOGIC; FLUORESCEINS; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; SPECIMEN HANDLING; STAINING AND LABELING;

EID: 85018656901     PISSN: 00221759     EISSN: 18727905     Source Type: Journal    
DOI: 10.1016/j.jim.2017.04.005     Document Type: Article

References (50)

1. Allsopp, C.E., Nicholls, S.J., et al. A flow cytometric method to assess antigen-specific proliferative responses of different subpopulations of fresh and cryopreserved human peripheral blood mononuclear cells. J. Immunol. Methods 214:1–2 (1998), 175–186.
2. Callewaert, D.M., Radcliff, G., et al. Characterization of effector-target conjugates for cloned human natural killer and human lymphokine activated killer cells by flow cytometry. Cytometry, 12, 1991, 666.
3. Cheng, Z.J., Garvin, D., et al. Development of a robust reporter-based ADCC assay with frozen, thaw-and-use cells to measure Fc effector function of therapeutic antibodies. J. Immunol. Methods 414 (2014), 69–81.
4. Cholujova, D., Jakubikova, J., et al. Comparative study of four fluorescent probes for evaluation of natural killer cell cytotoxicity assays. Immunobiology 213:8 (2008), 629–640.
5. Chung, S., Quarmby, V., et al. Quantitative evaluation of fucose reducing effects in a humanized antibody on Fcgamma receptor binding and antibody-dependent cell-mediated cytotoxicity activities. MAbs 4:3 (2012), 326–340.
6. Chung, S., Lin, Y.L., et al. Characterization of in vitro antibody-dependent cell-mediated cytotoxicity activity of therapeutic antibodies - impact of effector cells. J. Immunol. Methods 407 (2014), 63–75.
7. Cole, S.P., Multidrug resistance protein 1 (MRP1, ABCC1), a “multitasking” ATP-binding cassette (ABC) transporter. J. Biol. Chem. 289:45 (2014), 30880–30888.
8. Derer, S., Bauer, P., et al. Impact of epidermal growth factor receptor (EGFR) cell surface expression levels on effector mechanisms of EGFR antibodies. J. Immunol. 189:11 (2012), 5230–5239.
9. Digan, M.E., Pou, C., Niu, H., Zhang, J.-H., Evaluation of division-arrested cells for cell-based high-throughput screening and profiling. J. Biomol. Screen., 10, 2005, 615.
10. Essodaigui, M., Broxterman, H.J., et al. Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein. Biochemistry 37:8 (1998), 2243–2250.
11. Gillissen, M.A., Yasuda, E., et al. The modified FACS calcein AM retention assay: a high throughput flow cytometer based method to measure cytotoxicity. J. Immunol. Methods 434 (2016), 16–23.
12. Hatjiharissi, E., Xu, L., et al. Increased natural killer cell expression of CD16, augmented binding and ADCC activity to rituximab among individuals expressing the Fc{gamma}RIIIa-158 V/V and V/F polymorphism. Blood 110:7 (2007), 2561–2564.
13. Hollo, Z., Homolya, L., et al. Calcein accumulation as a fluorometric functional assay of the multi-drug transporter. Biochim. Biophys. Acta, 1191, 1994, 384.
14. Jang, Y.Y., Cho, D., et al. An improved flow cytometry-based natural killer cytotoxicity assay involving calcein AM staining of effector cells. Ann. Clin. Lab. Sci. 42:1 (2012), 42–49.
15. Jedema, I., van der Werff, N.M., et al. New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population. Blood 103 (2004), 2677–2682.
16. Jefferis, R., Antibody therapeutics: isotype and glycoform selection. Expert. Opin. Biol. Ther. 7:9 (2007), 1401–1413.
17. Jiang, X.R., Song, A., et al. Advances in the assessment and control of the effector functions of therapeutic antibodies. Nat. Rev. Drug Discov. 10:2 (2011), 101–111.
18. Jonsson, B., Liminga, G., et al. Cytotoxic activity of calcein acetoxymethyl ester (Calcein/AM) on primary cultures of human haematological and solid tumours. Eur. J. Cancer 32A:5 (1996), 883–887.
19. Kawai, S., Koishihara, Y., et al. Construction of a conventional non-radioisotope method to quantify HM1.24 antigens: correlation of HM1.24 levels and ADCC activity of the humanized antibody against HM1.24. Leuk. Res. 30:8 (2006), 949–956.
20. Koene, H.R., Kleijer, M., et al. Fc gammaRIIIa-158V/F polymorphism influences the binding of IgG by natural killer cell Fc gammaRIIIa, independently of the Fc gammaRIIIa-48L/R/H phenotype. Blood 90:3 (1997), 1109–1114.
21. Kolber, M.A., Quinones, R.R., et al. Measurement of cytotoxicity by target cell release and retention of the fluorescent dye bis-carboxyethyl-carboxyfluorescein (BCECF). J. Immunol. Methods 108 (1988), 255–264.
22. Konstantinus, I.N., Gamieldien, H., et al. Comparing high-throughput methods to measure NK cell-mediated antibody dependent cellular cytotoxicity during HIV-infection. J. Immunol. Methods 434 (2016), 46–52.
23. Kunapuli, P., Zheng, W., et al. Application of division arrest technology to cell-based HTS: comparison with frozen and fresh cells. Assay Drug Dev. Technol., 3, 2005, 17.
24. Lallemand, C., Kavrochorianou, N., et al. Reporter gene assay for the quantification of the activity and neutralizing antibody response to TNFalpha antagonists. J. Immunol. Methods 373:1–2 (2011), 229–239.
25. Lichtenfels, R., Biddison, W.E., et al. CARE-LASS (calcein-release-assay), an improved fluorescence-based test system to measure cytotoxic T lymphocyte activity. J. Immunol. Methods 172:2 (1994), 227–239.
26. Liminga, G., P. Nygren P, et al., Cytotoxic effect of calcein acetoxymethyl ester on human tumor cell lines: drug delivery by intracellular trapping. Anti-Cancer Drugs, 6, 1995, 578.
27. Maley, D., Simon, P., Cytotoxicity assay using cryopreserved target cells pre-labeled with the fluorescent marker europium. J. Immunol. Methods 134 (1990), 61–70.
28. Mata, M.M., Mahmood, F., et al. Effects of cryopreservation on effector cells for antibody dependent cell-mediated cytotoxicity (ADCC) and natural killer (NK) cell activity in (51)Cr-release and CD107a assays. J. Immunol. Methods 406 (2014), 1–9.
29. Mimura, K., Kono, K., et al. Trastuzumab-mediated antibody-dependent cellular cytotoxicity against esophageal squamous cell carcinoma. Clin. Cancer Res. 11:13 (2005), 4898–4904.
30. Neri, S., Mariani, E., et al. Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants. Clin. Diagn. Lab. Immunol. 8:6 (2001), 1131–1135.
31. Papadopoulos, N.G., Dedoussis, G.V., et al. An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry. J. Immunol. Methods 177:1–2 (1994), 101–111.
32. Patel, A.K., Boyd, P.N., An improved assay for antibody dependent cellular cytotoxicity based on time resolved fluorometry. J. Immunol. Methods 184:1 (1995), 29–38.
33. Patel, D., Guo, X., et al. IgG isotype, glycosylation, and EGFR expression determine the induction of antibody-dependent cellular cytotoxicity in vitro by cetuximab. Hum. Antibodies 19:4 (2010), 89–99.
34. Peipp, M., Lammerts van Bueren, J.J., et al. Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells. Blood 112:6 (2008), 2390–2399.
35. Pfeiffer, M., Stanojevic, S., et al. Rituximab mediates in vitro antileukemic activity in pediatric patients after allogeneic transplantation. Bone Marrow Transplant. 36:2 (2005), 91–97.
36. Pollara, J., Hart, L., et al. High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses. Cytometry A 79:8 (2011), 603–612.
37. Pross, H.F., Maroun, J.A., The standardization of NK cell assays for use in studies of biological response modifiers. J. Immunol. Methods 68:1–2 (1984), 235–249.
38. Raju, T.S., Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Curr. Opin. Immunol. 20:4 (2008), 471–478.
39. Robak, T., Robak, E., New anti-CD20 monoclonal antibodies for the treatment of B-cell lymphoid malignancies. BioDrugs 25:1 (2011), 13–25.
40. Roden, M.M., Lee, K.H., et al. A novel cytolysis assay using fluorescent labeling and quantitative fluorescent scanning technology. J. Immunol. Methods 226:1–2 (1999), 29–41.
41. Schnueriger, A., Grau, R., et al. Development of a quantitative, cell-line based assay to measure ADCC activity mediated by therapeutic antibodies. Mol. Immunol. 48:12 − 13 (2011), 1512–1517.
42. Shields, R.L., J. Lai J, et al., Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human Fcgamma RIII and antibody-dependent cellular toxicity. J. Biol. Chem. 277 (2002), 26733–26740.
43. Strong, D.M., Ortaldo, J.R., et al. Cryopreservation of human mononuclear cells for quality control in clinical immunology. I. Correlations in recovery of K- and NK-cell functions, surface markers, and morphology. J. Clin. Immunol. 2:3 (1982), 214–221.
44. TerWee, J.A., Chin, C.L., et al. Increased consistency and efficiency in routine potency testing by bioassay with direct use of cryopreserved (ready-to-plate) cells. J. Immunol. Methods 370:1–2 (2011), 65–74.
45. Wang, X.M., Terasaki, P.I., et al. A new microcellular cytotoxicity test based on calcein AM release. Hum. Immunol. 37:4 (1993), 264–270.
46. Weinberg, A., Song, L.Y., et al. Optimization and limitations of use of cryopreserved peripheral blood mononuclear cells for functional and phenotypic T-cell characterization. Clin. Vaccine Immunol. 16:8 (2009), 1176–1186.
47. 51Cr-labelled targets for natural killer cytotoxicity assays. J. Immunol. Methods, 122, 1989, 15.
48. Wu, Y., Li, J.J., et al. A neutralizing antibody assay based on a reporter of antibody-dependent cell-mediated cytotoxicity. AAPS J. 17:6 (2015), 1417–1426.
49. Zaman, G.J.R., de Roos, J.A.D.M., et al. Cryopreserved cells facilitate cell-based drug discovery. Drug Discov. Today, 12, 2007, 521.
50. von Zons, P., Crowley-Nowick, P., et al. Comparison of europium and chromium release assays: cytotoxicity in healthy individuals and patients with cervical carcinoma. Clin. Diagn. Lab. Immunol. 4:2 (1997), 202–207.